Search All News
CancerFIT—a free exercise program at CUIMC for cancer patients and survivors—offers more than a physical workout, it also provides much-needed support and inspiration.
Columbia biomedical engineers have designed a bacteria strain that seeks out solid tumors and safely delivers immunotherapies, resulting in tumor regression in mouse models.
The three scientists honored by the 2019 Horwitz Prize played key roles in identifying and deciphering the PI3K pathway, which has led to new treatments for several types of cancer.
By learning how contagious cancer spreads among shellfish, scientists hope to better understand how cancer metastasizes in people.
- September 28, 2018
Sarah Urke and Barbara Trencher, Columbia physical therapists and Velocity participants, developed an exercise program for cancer patients.
- September 20, 2018
Leaders in prostate cancer research and care will convene Sept. 22 for the inaugural NYC Prostate Cancer Summit, a patient-focused event co-hosted by CUIMC and NewYork-Presbyterian.
- August 27, 2018
Physician-scientist Darrell Yamashiro, MD, PhD, has been named director of Columbia's Division of Pediatric Hematology, Oncology, & Stem Cell Transplantation.
- July 30, 2018
Columbia researchers found that a gene associated with an autoimmune form of hair loss could be activated to improve cancer immunotherapy.
- July 10, 2018
Acupuncture significantly eased joint pain for a majority of women undergoing a common form of breast cancer treatment, a new study found.
- July 5, 2018
A very low carbohydrate, high-fat diet called the ketogenic diet may improve the effectiveness of an emerging class of cancer drugs, according to a study in mice.
- June 29, 2018
Cell-based therapy expert Pawel Muranski, MD, discusses the challenges of testing cancer immunotherapy drugs in new patient groups.
- June 20, 2018
Columbia researchers discover that DNA repair falters when cells can’t move damaged DNA to repair centers within the nucleus. The results could lead to better cancer treatments.
- June 6, 2018
Cachexia, the debilitating muscle wasting that occurs in late-stage cancer patients, may be due to an overload of zinc in muscles, finds a new study.